received advisory/consulting fees and/or other support from Altimmune, AstraZeneca, Bayer, Biomea, Boehringer Ingelheim, Carmot Therapeutics, Cytoki Pharma, Eli Lilly, Intercept, Janssen/Johnson & Johnson, Mannkind, Mediflix, Merck, Metsera, Novo Nordisk, Pharmaventures, Pfizer, Regeneron, Sanofi, Shionogi, Structure Therapeutics, Target RWE, Terns Pharmaceuticals, The Comm Group, Valeritas, WebMD and Zealand Pharma
BPC-157 is not a steroid, not a hormone, and not a stimulant
The mechanisms, dosing, and effects are the same
visceral fat fell about 40%. After withdrawal, insulin resistance returned in proportion to regained weight. Maintaining some weight loss did not preserve the full metabolic benefit when substantial regain occurred
There are several potential benefits of Lipo Mino injections, including weight loss, increased energy levels, reduced appetite, and improved liver function.
Because effect sizes vary by indication, dosing, individual factors, and adherence, a thoughtful provider frames frequency as something to reassess rather than fix permanently